Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 275 of 1,261
  1. US 11286305

    Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA

    Dyne Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  2. US 11286352

    Process for preparation of beads for imaging

    Stichting Radboud universitair medisch centrum · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  3. US 11286282

    Methods of detection and removal of rhabdoviruses from cell lines

    Takeda Vaccines, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  4. US 11285210

    Buffer formulations for enhanced antibody stability

    Outlook Therapeutics, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  5. US 11285215

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  6. US 11285214

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  7. US 11286265

    Macrocyclic compounds for treating disease

    TURNING POINT THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  8. US 11286264

    Macrocyclic compounds and uses thereof

    TURNING POINT THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  9. US 11285213

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  10. US 11286463

    Reprogramming of aged adult stem cells

    Advanced ReGen Medical Technologies, LLC · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  11. US 11285190

    CLEC11a is a bone growth agent

    The Board of Regents of the University of Texas System · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  12. US 11285182

    Reduction of milk glycans and their degradation products in the neonate gut

    The Regents of the University of California · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  13. US 11285184

    Cannabidiol alkaline composition

    CHIROSYN DISCOVERY TECHNOLOGIES INC. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  14. US 11285178

    Fertilized egg isolate and uses thereof

    United Paragon Associates, Inc. · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  15. US 11285165

    Selective high-affinity polydentate ligands and methods of making such

    The Regents of the University of California · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  16. US 11285154

    Methods and compositions for treating cancer

    United States Government as represented by the Department of Veterans Affairs · Granted Mar 29, 2022 · Expires Mar 24, 2042

    granted
  17. US 11279763

    Integrin alpha 9 blockade suppresses lymphatic valve formation and promotes transplant survival

    The Regents of the University of California · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  18. US 11279922

    Delivery of therapeutic agents by a collagen binding protein

    Montefiore Medical Center · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  19. US 11279713

    Heterocyclic compound and use thereof

    Takeda Pharmaceutical Company Limited · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  20. US 11278632

    Engineered nucleases useful for treatment of hemophilia A

    Precision BioSciences, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  21. US 11278619

    DNA antibody constructs and method of using same

    Inovio Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  22. US 11278592

    Methods and compositions for TUSC2 immunotherapy

    The Board of Regents of the University of Texas System · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  23. US 11279686

    Nrf2 activating compounds and uses thereof

    Rigel Pharmaceuticals, Inc. · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted
  24. US 11278626

    Compositions of polymeric nanowires and methods of making and using thereof

    The Regents of the University of California · Granted Mar 22, 2022 · Expires Mar 17, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.